Royalties
Participation in the economics of validated science.
Royalty structures are defined asset by asset, with transparent accounting, quarterly reporting and audit rights for every counterparty.
Open positions
Royalty terms under structuring.
No royalty percentage, term or exclusivity is published yet. Each structure is negotiated asset by asset and disclosed under NDA once the licence is executed — we do not publish indicative percentages before that.
In structuring
Assets open for licensing.
AXW-001
Oral-dissolving solid matrix technology platform — functional no-added-sugar lollipop containing protected lactase
Platform · TRL 7
AXW-002AURA HEALTH FINANCE — Behavioral Health & Financial Intelligence Platform
Platform · TRL 6
AXW-003ABIP Nutritional Phytochemical Platform™
Platform · TRL 5
AXW-006ABIP — Multicomponent functional nutritional formulation for intervention in child malnutrition
Formulation · TRL 5
AXW-008BioCurauá Project — Curauá gM GlucoCare
R&D project · TRL 5
AXW-009CannabiMod-P™ Onco
Technology · TRL 4
AXW-011NutraSeq™
Technology · TRL 4
AXW-012ImmunoAfrica™
R&D project · TRL 5
AXW-013ZimKids Cognition™
R&D project · TRL 6
AXW-014NutraRegen™ Adaptive Metabolic Modulator for Severe Malnutrition and Cachexia
Formulation · TRL 5
AXW-015HERBAL SCIENCE For Men's Health
Product · TRL 8
AXW-016Improve For Man Line — Inovattis Health Science
Product · TRL 8
AXW-017Brain Kids Global Project — Child cognitive and emotional supplementation with international scientific validation
R&D project · TRL 7
AXW-018NitraBeet™ — Cardiovascular bioactive complex of natural beetroot nitrates and nitrites with encapsulated magnesium
Formulation · TRL 4